文献速递新生儿

加强新生儿试验结局报告

Strengthening Reporting of Neonatal Trials.
PubMed 文献 · Pediatrics · 2023-01-01

该研究从2015至2020年发表、每组超过100例且主要结局属于新生儿核心结局集的新生儿试验中,用CONSORT 2010与CONSORT-Outcomes 2022评估报告质量,提取了生存、短期新生儿并发症和长期发育结局三类良好报告范例,以指导未来试验完整报告结局。

要点

  • 新生儿试验结局选择与报告存在变异,关键信息常缺失,影响证据合成与适用性。
  • 参照这些范例报告结局可改善信息传递并减少研究浪费。

核心结论

  • 已识别出符合CONSORT 2010和CONSORT-Outcomes 2022的良好试验结局报告范例,可指导新生儿重要结局的规范报告。

研究设计与样本

  • 纳入2015至2020年发表、每组超过100例且主要结局属于新生儿核心结局集的新生儿试验,由Cochrane Neonatal招募的39名评估者用CONSORT 2010和CONSORT-Outcomes 2022审查主要结局报告。

关键数值与推荐

  • 纳入标准为每组超过100例、2015至2020年发表且主要结局包含在新生儿核心结局集中的试验。

临床怎么用

  • 未来新生儿试验发表时应参照这些范例报告结局,以符合CONSORT 2010和CONSORT-Outcomes 2022要求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: There is variability in the selection and reporting of outcomes in neonatal trials with key information frequently omitted. This can impact applicability of trial findings to clinicians, families, and caregivers, and impair evidence synthesis. The Neonatal Core Outcomes Set describes outcomes agreed as clinically important that should be assessed in all neonatal trials, and Consolidated Standards of Reporting Trials (CONSORT)-Outcomes 2022 is a new, harmonized, evidence-based reporting guideline for trial outcomes. We reviewed published trials using CONSORT-Outcomes 2022 guidance to identify exemplars of neonatal core outcome reporting to strengthen description of outcomes in future trial publications. METHODS: Neonatal trials including >100 participants per arm published between 2015 to 2020 with a primary outcome included in the Neonatal Core Outcome Set were identified. Primary outcome reporting was reviewed using CONSORT 2010 and CONSORT-Outcomes 2022 guidelines by assessors recruited from Cochrane Neonatal. Examples of clear and complete outcome reporting were identified with verbatim text extracted from trial reports. RESULTS: Thirty-six trials were reviewed by 39 assessors. Examples of good reporting for CONSORT 2010 and CONSORT-Outcomes 2022 criteria were identified and subdivided into 3 outcome categories: "survival," "short-term neonatal complications," and "long-term developmental outcomes" depending on the core outcomes to which they relate. These examples are presented to strengthen future research reporting. CONCLUSIONS: We have identified examples of good trial outcome reporting. These illustrate how important neonatal outcomes should be reported to meet the CONSORT 2010 and CONSORT-Outcomes 2022 guidelines. Emulating these examples will improve the transmission of information relating to outcomes and reduce associated research waste.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Webbe J, Baba A, Butcher NJ, et al. Strengthening Reporting of Neonatal Trials. Pediatrics. 2023. PMID: 37641894. doi:10.1542/peds.2022-060765

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。